Sorry, you need to enable JavaScript to visit this website.

DEXTROSE (Dextrose ADD-Vantage™ Diluent) Indications and Usage


Intravenous solutions containing dextrose are indicated for parenteral replenishment of fluid and minimal carbohydrate calories as required by the clinical condition of the patient.

In this dosage form, 5% Dextrose Injection, USP is intended to be used as a diluent for the contents of an ADD-Vantage vial, or single-dose vials with 20 mm closure using the ADD-Vantage ADDAPTORTM.

What's New

No Current Announcements.

Contact Pfizer Medical


Please enter your search term(s) for DEXTROSE